254 related articles for article (PubMed ID: 25515823)
1. Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy.
Haslik W; Hacker S; Felberbauer FX; Thallinger C; Bartsch R; Kornauth C; Deutschmann C; Mader RM
Eur J Surg Oncol; 2015 Mar; 41(3):378-85. PubMed ID: 25515823
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous wash-out procedure (SWOP) for the treatment of chemotherapeutic extravasations.
Steiert A; Hille U; Burke W; Gohritz A; Zilz S; Herold C; Vogt PM
J Plast Reconstr Aesthet Surg; 2011 Feb; 64(2):240-7. PubMed ID: 20542747
[TBL] [Abstract][Full Text] [Related]
3. Recognition of a new chemotherapeutic vesicant: trabectedin (ecteinascidin-743) extravasation with skin and soft tissue damage.
Theman TA; Hartzell TL; Sinha I; Polson K; Morgan J; Demetri GD; Orgill DP; George S
J Clin Oncol; 2009 Nov; 27(33):e198-200. PubMed ID: 19805684
[No Abstract] [Full Text] [Related]
4. [Chemotherapy drug extravasation in totally implantable venous access port systems: use of subcutaneous wash-out technique (with vidéo)].
Taibi A; Ferrero PA; Derbal S
Gynecol Obstet Fertil Senol; 2020 Apr; 48(4):398-399. PubMed ID: 31991173
[No Abstract] [Full Text] [Related]
5. Extravasation of Pt-based chemotherapeutics - bioimaging of their distribution in resectates using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS).
Egger AE; Kornauth C; Haslik W; Hann S; Theiner S; Bayer G; Hartinger CG; Keppler BK; Pluschnig U; Mader RM
Metallomics; 2015 Mar; 7(3):508-15. PubMed ID: 25659827
[TBL] [Abstract][Full Text] [Related]
6. Surgical management after doxorubicin and epirubicin extravasation.
Heitmann C; Durmus C; Ingianni G
J Hand Surg Br; 1998 Oct; 23(5):666-8. PubMed ID: 9821616
[TBL] [Abstract][Full Text] [Related]
7. Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.
Pluschnig U; Haslik W; Bayer G; Soleiman A; Bartsch R; Lamm W; Steger GG; Zielinski CC; Mader RM
Support Care Cancer; 2015 Jun; 23(6):1741-8. PubMed ID: 25433440
[TBL] [Abstract][Full Text] [Related]
8. [Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
Weber M; Meyer F; Halloul Z
Zentralbl Chir; 2009 Aug; 134(4):350-6. PubMed ID: 19688684
[TBL] [Abstract][Full Text] [Related]
9. [Clinical manifestation of extravasation caused by infusion and its therapeutic management].
Altmann S; Damert HG; Schneider W
Zentralbl Chir; 2014 Feb; 139(1):83-8. PubMed ID: 21598203
[TBL] [Abstract][Full Text] [Related]
10. The wash-out technique in the management of delayed presentations of extravasation injuries.
Dionyssiou D; Chantes A; Gravvanis A; Demiri E
J Hand Surg Eur Vol; 2011 Jan; 36(1):66-9. PubMed ID: 20682583
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy drug extravasation in totally implantable venous access port systems: how effective is early surgical lavage?
Azaïs H; Bresson L; Bassil A; Katdare N; Merlot B; Houpeau JL; El Bedoui S; Meurant JP; Tresch E; Narducci F
J Vasc Access; 2015; 16(1):31-7. PubMed ID: 25362986
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of saline washout technique in the management of exfoliant and vesicant chemotherapy extravasation: a historical case series report.
Harrold K; Gould D; Drey N
Eur J Cancer Care (Engl); 2013 Mar; 22(2):169-78. PubMed ID: 23320981
[TBL] [Abstract][Full Text] [Related]
13. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy.
Poorter RL; Lauw FN; Bemelman WA; Bakker PJ; Taat CW; Veenhof CH
Eur J Cancer; 1996 Dec; 32A(13):2262-6. PubMed ID: 9038608
[TBL] [Abstract][Full Text] [Related]
14. Epirubicin extravasation: consequences of delayed management.
Hale O; Deutsch PG; Lahiri A
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28062432
[TBL] [Abstract][Full Text] [Related]
15. Extravasation of paclitaxel into breast tissue from central catheter port.
Barutca S; Kadikoylu G; Bolaman Z; Meydan N; Yavasoglu I
Support Care Cancer; 2002 Oct; 10(7):563-5. PubMed ID: 12324812
[TBL] [Abstract][Full Text] [Related]
16. [Extravasation of cytostatics. Example of a severe complication from the use of long-term central venous catheters].
Bach F; Videbaek C; Holst-Christensen J; Boesby S
Ugeskr Laeger; 1991 Oct; 153(41):2896-7. PubMed ID: 1949309
[TBL] [Abstract][Full Text] [Related]
17. Vesicant characteristics of oxaliplatin following antecubital extravasation.
Kennedy JG; Donahue JP; Hoang B; Boland PJ
Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):237-9. PubMed ID: 12924452
[TBL] [Abstract][Full Text] [Related]
18. Negative-pressure wound therapy and early pedicle flap reconstruction of the chest wall after epirubicin extravasation.
Papadakis M; Rahmanian-Schwarz A; Bednarek M; Arafkas M; Holschneider P; Hübner G
J Vasc Access; 2017 May; 18(3):e27-e29. PubMed ID: 28165571
[TBL] [Abstract][Full Text] [Related]
19. Managing chemotherapy extravasation in totally implantable central venous access: Use of subcutaneous wash-out technique.
Taibi A; Bardet M S; Durand Fontanier S; Deluche E; Fredon F; Christou N; Usseglio J; Mathonnet M
J Vasc Access; 2020 Sep; 21(5):723-731. PubMed ID: 32056485
[TBL] [Abstract][Full Text] [Related]
20. [Soft-tissue defects on the dorsum of the hand by extravasation of the cytostatic agents: surgical options of treatment].
Damert HG; Lenz-Scharf O; Altmann S; Schneider W
Handchir Mikrochir Plast Chir; 2007 Dec; 39(6):409-13. PubMed ID: 18058671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
